MedFirst Healthcare Services, Inc. (TW) (4175) AI Stock Analysis

MedFirst Healthcare Services, Inc. (TW)

(TPEx:4175)

Select Model

Rating:64Neutral

Price Target:TWD 52.00▲(4.00% Upside)

Action:initiatedcoverage

Date:11/10/26

The score is supported primarily by materially improved financial performance and attractive valuation. These strengths are tempered by high leverage and weak technical momentum, despite oversold readings that may limit further downside.

Positive Factors

Strong Revenue GrowthThe sharp 2025 revenue acceleration indicates materially expanding business activity and provides a stronger base for future earnings growth. If the higher sales level is maintained, it can improve operating scale, support investment, and strengthen the company’s position over the next several quarters.

Negative Factors

Thin Net ProfitabilityA net margin of only 1.9% leaves limited room to absorb cost increases, weaker demand, or execution setbacks. Even with year-over-year improvement, the company converts a relatively small share of revenue into profit, which can make earnings less resilient and constrain internally funded growth.

MedFirst Healthcare Services, Inc. (TW) (4175) vs. SPDR S&P 500 ETF (SPY)

Market Cap: TWD 2.11B
Dividend Yield: 6.00%
Average Volume (3M): 11.04K
Price to Earnings (P/E): 13.2
Beta (1Y): 0.21
Revenue Growth: 2.49%
EPS Growth: 5.18%
Country: TW
Employees: 150
Sector: General
Sector Strength: 55
Industry: Medical - Distribution

MedFirst Healthcare Services, Inc. (TW) Business Overview & Revenue Model

Company Description

MedFirst Healthcare Services, Inc., established in 1990 and headquartered in Taoyuan City, Taiwan, is a prominent distributor of medical supplies throughout Taiwan and China. The company's diverse product range includes diabetes management items, res...

MedFirst Healthcare Services, Inc. (TW) Financial Statement Overview

Summary

Strong 2025 revenue growth, improved profitability, and higher operating and free cash flow are offset by thin net margins, volatile historical cash flow, and high leverage.

Income Statement

72Positive

Balance Sheet

60Neutral

Cash Flow

67Positive

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	8.06B	8.01B	7.73B	7.45B	7.22B	6.54B
Gross Profit	2.65B	2.60B	2.38B	2.27B	2.21B	1.93B
EBITDA	794.07M	991.07M	924.25M	873.32M	940.99M	686.17M
Net Income	160.34M	155.57M	69.81M	46.80M	170.86M	67.93M
Balance Sheet
Total Assets	7.31B	7.28B	7.12B	7.63B	7.55B	6.81B
Cash, Cash Equivalents and Short-Term Investments	570.70M	533.99M	624.58M	961.38M	1.01B	841.36M
Total Debt	3.52B	3.59B	3.64B	3.88B	3.94B	3.61B
Total Liabilities	5.78B	5.72B	5.66B	6.18B	6.19B	5.63B
Stockholders Equity	1.52B	1.56B	1.46B	1.45B	1.36B	1.17B
Cash Flow
Free Cash Flow	850.53M	624.41M	404.82M	572.08M	805.35M	587.94M
Operating Cash Flow	982.35M	903.97M	542.24M	795.40M	1.07B	1.00B
Investing Cash Flow	-167.87M	-307.49M	-207.97M	-253.30M	-221.49M	-397.75M
Financing Cash Flow	-818.76M	-715.11M	-754.72M	-603.48M	-611.30M	-188.06M

MedFirst Healthcare Services, Inc. (TW) Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

TW:4175 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TW:4138	68Neutral	TWD 2.15B	15.66	―	7.75%	-1.10%	-16.90%
TW:4155	64Neutral	TWD 2.19B	10.00	―	1.78%	-10.90%	―
TW:4175	64Neutral	TWD 2.09B	13.16	―	6.00%	2.49%	5.18%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
TW:4747	53Neutral	TWD 1.60B	-23.25	―	3.32%	4.56%	-172.55%
TW:4108	47Neutral	TWD 2.06B	-48.44	―	―	1.10%	54.83%
TW:6796	40Underperform	TWD 2.04B	123.00	―	0.51%	12.26%	―

* General Sector Average

Performance Comparison

TW:4175 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
TW:4175	MedFirst Healthcare Services, Inc. (TW)	50.00	-3.90	-7.23%
TW:4108	Phytohealth Corporation	10.40	-3.90	-27.27%
TW:4138	Dynamic Medical Technologies Inc.	54.20	-5.23	-8.80%
TW:4155	Ok Biotech Co., Ltd.	16.90	1.37	8.84%
TW:4747	Johnson Chemical Pharmaceutical Works Co., Ltd.	15.80	-15.43	-49.41%
TW:6796	Medimaging Integrated Solution Inc.	49.20	-39.14	-44.31%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 09, 2026

MedFirst Healthcare Services, Inc. (TW) AI Stock Analysis